Clinical Updates

Drug approvals, guideline changes, and treatment advances

First-in-Human Trial Tests Immune-Engineered Cells for Type 1 Diabetes Without Lifelong Immunosuppression

Researchers have launched the first human trial of immune-engineered insulin-producing cells designed to function without lifelong immunosuppressive drugs, a breakthrough…

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.

More form Clinical Updates

FDA Issues Correction Notice for TRUE METRIX Blood Glucose Monitors Over Error Code Risk

Trividia Health has issued a correction notice for TRUE METRIX blood glucose monitors after reports…

Dexcom Signals Expansion Beyond Diabetes as CGM Technology Reshapes Health Monitoring

Dexcom's leadership has signalled plans to expand continuous glucose monitoring beyond diabetes management into weight…

Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network